Genetic and Environmental Contributions to Cardiovascular Risk: Lessons From North Karelia and FINRISK

Global Heart

Volumn 11, Issue 2, 2016, Pages 229-233

  Salomaa, Veikko ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIASTOLIC BLOOD PRESSURE; ELECTRONIC HEALTH RECORD; ENVIRONMENTAL FACTOR; EXOME; FINLAND; FINN (CITIZEN); GENETIC BACKGROUND; GENETIC RISK; GENETIC VARIABILITY; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HERITABILITY; HISTORY; HUMAN; POPULATION RESEARCH; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE; ENVIRONMENTAL EXPOSURE; GENETIC PREDISPOSITION; GENETICS; MORBIDITY; PROCEDURES; RISK FACTOR; TRENDS;

CARDIOVASCULAR DISEASES; ENVIRONMENTAL EXPOSURE; FINLAND; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MORBIDITY; RISK FACTORS;

EID: 85008645120     PISSN: 22118160     EISSN: 22118179     Source Type: Journal    
DOI: 10.1016/j.gheart.2016.04.008     Document Type: Review

References (13)

1. 1 Jousilahti, P., Puska, P., Vartiainen, E., Pekkanen, J., Tuomilehto, J., Parental history of premature coronary heart disease: an independent risk factor of myocardial infarction. J Clin Epidemiol 49 (1996), 497–503.
2. 2 Jousilahti, P., Rastenyte, D., Tuomilehto, J., Sarti, C., Vartiainen, E., Parental history of cardiovascular disease and risk of stroke. A prospective follow-up of 14371 middle-aged men and women in Finland. Stroke 28 (1997), 1361–1366.
3. 3 Ripatti, S., Tikkanen, E., Orho-Melander, M., et al. A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses. Lancet 376 (2010), 1393–1400.
4. 4 Havulinna, A.S., Kettunen, J., Ukkola, O., et al. A blood pressure genetic risk score is a significant predictor of incident cardiovascular events in 32,669 individuals. Hypertension 61 (2013), 987–994.
5. 5 Surakka, I., Horikoshi, M., Mägi, R., et al. The impact of low-frequency and rare variants on lipid levels. Nat Genet 47 (2015), 589–597.
6. 6 Lim, E.T., Würtz, P., Havulinna, A.S., et al. Distribution and medical impact of loss-of-function variants in the Finnish founder population. PLoS Genet, 10, 2014, e1004494.
7. 7 Surakka, I., Kristiansson, K., Anttila, V., et al. Founder population-specific HapMap panel increases power in GWA studies through improved imputation accuracy and CNV tagging. Genome Res 20 (2010), 1344–1351.
8. 8 Kettunen, J., Tukiainen, T., Sarin, A.P., et al. Genome-wide association study identifies multiple loci influencing human serum metabolite levels. Nat Genet 44 (2012), 269–276.
9. 9 Salomaa, V., Pietilä, A., Peltonen, M., Kuulasmaa, K., Changes in CVD incidence and mortality rates, and life expectancy: North Karelia and National. Glob Heart 11 (2016), 201–205.
10. 10 Nora, J.J., Lortscher, R.H., Spangler, R.D., Nora, A.H., Kimberling, W.J., Genetic-epidemiologic study of early-onset ischemic heart disease. Circulation 61 (1980), 503–508.
11. 11 Marenberg, M.E., Risch, N., Berkman, L.F., Floderus, B., de Faire, U., Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 330 (1994), 1041–1046.
12. 12 Kannisto, V., Kuolemansyyt väestöllisinä tekijöinä Suomessa. Kansantaloudellisia tutkimuksia 17. Helsinki; University of Helsinki, 1947.
13. 13 Peltonen, L., Palotie, A., Lange, K., Use of population isolates for mapping complex traits. Nat Rev Genet 1 (2000), 182–190.